Abstract
Aim
Recent advances in immunohistochemical techniques have made it possible to identify micrometastasis using antibodies to cytokeratins (CK). The aim of the study was to determine the prevalence and prognostic significance of immunohistochemically detected micrometastasis (IHM) in patients with localised colorectal cancer (CRC) (Dukes’ A and B). A further aim was to study the prognostic role of histopathological factors such as vascular invasion.
Methods
The original histology of 168 consecutive patients with Dukes’ A or B tumours who had undergone curative resection was reviewed. Immunohistochemical staining was performed using CK antibodies, AE1/AE3 and MNF116 on all (n=898) lymph nodes. Survival analysis was performed on 105 cases that had been followed up until death or for at least 5 years.
Results
IHM were detected in 17.3% of lymph nodes analysed. Adverse outcome (death/local recurrence) was recorded in 8/49 (16%) patients with IHD-positive nodes and in 10/56 (18%) patients negative for IHM. IHM was not associated with adverse outcome on either univariate (p=0.540) or multivariate analyses (p=0.673). There was no correlation of IHM with age, gender, site, size and grade of tumour, depth of tumour invasion or perineural and vascular invasion. Vascular invasion was the only independent prognostic factor identified.
Discussion
We have shown that isolated CK-positive epithelioid cells are commonly found in morphologically benign pericolic lymph nodes of patients with localised (Dukes’ A or B) CRC. These cells may represent occult micrometastasis but are not clinically significant. Vascular invasion identifies patients with localised CRC likely to develop recurrences or die of disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Office for National Statistics (2000) Health statistics Quarterly 6. ONS, London, Summer
Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67:1859–1861
McArdle CS, Hole D, Hansell D et al (1990) Prospective study of colorectal cancer in the West of Scotland: ten year follow up. Br J Surg 77:280–282
Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive possibilities. Am J Surg Pathol 26:179–189
Haboubi NY, Clark P, Kaftan SM et al (1992) The importance of Xylene clearance and immunohistochemistry in the accurate staging of colorectal cancer. J R Soc Med 85:386–388
Wyk QV, Hosie KB, Balsitis M (2000) Histopathological detection of lymph node metastases from colorectal carcinoma. J Clin Pathol 53:685–687
Doglioni C, Dell’Orto P, Zanetti G et al (1990) Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological condition. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 416:479–490
Xu X, Roberts SA, Pasha TL, Zhang PJ (2000) Undesirable cytokeratin immunoreactivity of native non epithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Path Lab 124:1310–1313
Moertel CG, Fleming TR, MacDonald JS et al (1989) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358
Impact B2 investigators (1999) Efficacy of adjuvant fluorouracil and folinic acid in B 2 colon cancer. J Clin Oncol 17:1356–1363
Adell G, Boeryd B, Franlund B (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637–642
Greenson JK, Isenhart CE, Rice R et al (1994) Identification of Occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73:563–569
Cutait R, Alves VA, Lopes LC et al (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917–920
Jeffers MD, O’Dowd GM, Mulcahy H et al (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal cancer. J Pathol 172:183–187
Clarke G, Ryan E, Keane JC et al (2000) The detection of cytokeratins in lymph nodes of Dukes B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 12:549–552
Broll R, Schauer V, Schimmelpenning H et al (1997) Prognostic relevance of Occult tumour cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 40:1465–1471
Bertoglio S, Percivale P, Gambini C et al (1997) Cytokeratin immunostaining reveals micrometastasis in negative haematoxylin-eosin lymph nodes of resected stage 1–2(pT2-pT3) colorectal cancer. J Chemother 9:119–120
Nakanishi Y, Ochiai A, Yamauchi Y et al (1999) Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 57:276–280
Garcia-Saenz J, Saenz M, Gonzalaz L et al (2006) Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Trans Oncol 8:676–680
Bilchik A, Hoon D, Saha S et al (2007) Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 246:568–575
Colpaert C, Vermeulen P, Jeuris W et al (2001) Early distant relapse in node negative breast cancer patients is not predicted by occult axillary lymph nodes metastases but by the feature of the primary tumour. J Pathol 193:442–449
Nasser IA, Lee AK, Bosari S et al (1993) Occult axillary lymph node metastases in node negative breast carcinoma. Hum Pathol 24:950–957
Doekhie F, Kuppen P, Peeters K et al (2006) Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer. Eur J Surg Oncol 32:253–258
Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ (2007) Is occult lymph node disease in colorectal cancer patients clinically significant?: A review of the relevant literature. J Mol Diagn 9:563–571
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented to Royal Australasian College of Surgeons annual meeting, Adelaide (2002) and Association of Coloproctology of GB and Ireland, annual meeting, Manchester, UK (2002)
Rights and permissions
About this article
Cite this article
Davies, M., Arumugam, P.J., Shah, V.I. et al. The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer. Clin Transl Oncol 10, 175–179 (2008). https://doi.org/10.1007/s12094-008-0176-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0176-y